GeneDx is trading at $80.50 (-5.08%) after a broad risk-off move across U.S. equity futures.
- S&P 500, Nasdaq Composite, and Dow futures are all lower.
- Rising global bond yields and geopolitical concerns are pressuring risk assets.
- No clear company-specific announcement, earnings update, or analyst action was identified; technical selling and profit-taking were reported as likely factors.